Effects of 5-fluorouracil treatment on rat liver microsomal enzymes

References

• Alarcon R. A. Fluoremetric determination of acrolein and related compounds with m-aminophenol. Analytical Chemistry 1968; 40: 1704–1708
   PubMed Web of Science ®Google Scholar
• Bonadonna G., Valagussa P. The contribution of medicine to the primary treatment of breast cancer. Cancer Research 1988; 48: 2314–2324
   PubMed Web of Science ®Google Scholar
• Cantrill E., Murray M., Mehta I., Farrell G. C. Down regulation of male specific hepatic microsomal steroid-16α hydroxylase, cytochrome P-450 UT-A, in rats with portal bypass. Relevance to oestradiol accumulation and impaired drug metabolism in hepatic cirrhosis. Journal of Clinical Investigation 1989; 83: 1211–1216
   PubMed Web of Science ®Google Scholar
• Clarke L., Waxman D. J. Oxidative metabolism of cyclophosphamide: identification of the hepatic monooxygenase catalysts of drug activation. Cancer Research 1989; 49: 2344–2350
   PubMed Web of Science ®Google Scholar
• Conners T. A., Cox P. J., Farmer P. B., Foster A. B., Jarman M. Some studies of the active metabolites formed in the microsomal metabolism of cyclophosphamide and isophos-phamide. Biochemical Pharmacology 1974; 23: 115–119
   Google Scholar
• Donelli M. G., Franchi G., Rosso R. The effect of cytotoxic agents on drug metabolism. European Journal of Cancer 1970; 6: 125–126
   PubMed Web of Science ®Google Scholar
• Donelli M. G., Garattini S. Drug metabolism after repeated treatments with cytotoxic agents. European Journal of Cancer 1971; 7: 361–364
   PubMed Web of Science ®Google Scholar
• El Kouni M. H., Naguib F. M. N., Cha S. Circadian rhythm of dihydrouracil dehydrogenase (DHUDase), uridine phosphorylase (UrdPase) and thymidine phosphorylase (dThdPase) in mouse liver. FASEB Journal 1989; 3: A397
   Google Scholar
• Gonzalez F. J. Molecular genetics of the P-450 superfamily. Pharmacology and Therapeutics 1990; 45: 1–38
   PubMed Web of Science ®Google Scholar
• Harris B. E., Song R., Soong, Diasio R. B. Circadian variation of 5 -fluorouracil catabolism in isolated perfused rat liver. Cancer Research, 49: 6610–6614
   Google Scholar
• Imai Y., Ito A., Sato R. Evidence for biochemically different types of vesicles in the hepatic microsomal fraction. Journal of Biochemistry (Tokyo) 1966; 60: 417–427
   PubMed Web of Science ®Google Scholar
• Koop D. Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P450 isozyme 3a. Molecular Pharmacology 1986; 29: 399–404
   PubMed Web of Science ®Google Scholar
• Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
   PubMed Web of Science ®Google Scholar
• Lear L., Nation R. L., Stupans I. Influence of morphine concentration on detergent activation of rat liver morphine-UDP-glucuronosyltransferase. Biochemical Pharmacology 1991; 42(Suppl)S55–60
   PubMedGoogle Scholar
• Le Blanc G. A., Waxman D. J. Feminization of rat hepatic P450 expression by cisplatin. Journal of Biological Chemistry 1988; 263: 15732–15739
   Google Scholar
• Le Blanc G. A., Waxman D. J. Mechanisms of cyclophosphamide action on hepatic P-450 expression. Cancer Research 1990; 50: 5720–5726
   PubMedGoogle Scholar
• Le Blanc G. A., Sundseth S. S., Weber G. F., Waxman D. J. Platinum anticancer drugs modulate P-450 mRNA levels and differentially alter hepatic drug and steroid hormone metabolism in male and female rats. Cancer Research 1992; 52: 540–547
   Google Scholar
• Maines M. D. Differential effect of cis-platinum (cls-diamminedichloroplatinum) on regulation of liver and kidney haem and haemoprotein metabolism. Biochemical Journal 1986; 237: 713–721
   PubMed Web of Science ®Google Scholar
• McClure M. T., Stupans I. Investigation of the mechanism by which cyclophosphamide alters cytochrome P450 in male rats. Biochemical Pharmacology 1992; 43: 2655–2658
   PubMed Web of Science ®Google Scholar
• McManus M. E., Felton J. S., Burgess W. M., Roberts-Thomson S., Stupans I., Veronese M. E. Activation of the food-derived mutagen 2-amino-a-methyl-6-phenyl imidazo (4,5,b) pyridine by rabbit and human liver microsomes and purified forms of cytochrome P450. Carcinogenesis 1989; 10: 357–363
   PubMedGoogle Scholar
• Ng S., Waxman D. J. Biotransformation of N,N',N',-triethylenethiophosphoramide: oxidative desulfuration to yield N, N', N',-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase. Cancer Research 1990; 50: 464–471
   Google Scholar
• Potter D. W., Levin W., Ryan D. E., Thomas P. E., Reed D. J. Stereoselective monooxygenation of carcinostatic 1-(2-chloroethyl)-3-(cyclohexyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea by purified cytochrome P-450 isozymes. Biochemical Pharmacology 1984; 33: 609–613
   PubMed Web of Science ®Google Scholar
• Prough R. A., Brown M. I., Dannan G. A., Guengerich F. P. Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-a-(2-methylazo)-p-toluamide, the azo derivative of procarbazine. Cancer Research 1984; 44: 543–548
   PubMed Web of Science ®Google Scholar
• Sladek N. E. Metabolism of oxazaphosphorines. Pharmacology and Therapeutics 1988; 37: 301–355
   PubMed Web of Science ®Google Scholar
• Stupans I., Sansom L. N. The inhibition of drug oxidation by anhydroerythromycin, an acid degradation product of erythromycin. Biochemical Pharmacology 1991; 42: 2085–2090
   PubMed Web of Science ®Google Scholar
• Waxman D. J., Ko A., Walsh C. Regioselectivity and stereoselectivity of androgen hydroxylations catalysed by cytochrome P450 isozymes purified from phenobarbital-induced rat liver. Journal of Biological Chemistry 1983; 258: 11937–11947
   PubMed Web of Science ®Google Scholar
• Waxman D. J., Dannan G. A., Guengerich F. P. Regulation of rat hepatic cytochrome P450: age dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes. Biochemistry 1985; 24: 4409–4417
   PubMed Web of Science ®Google Scholar
• Waxman D. J., Morrissey J. J., LeBlanc G. A. Female predominant rat hepatic cytochrome P450 forms j(IIE1) and 3(IIA1) are under hormonal regulatory controls distinct from those of the sex-specific P450 forms. Endocrinology 1989; 124: 2954–2966
   PubMed Web of Science ®Google Scholar
• Zaphiropoulos P. G., Ström A., Robertson J. A., Gustafsson J.-A. Structural and regulatory analysis of the male specific rat liver cytochrome P-450g: repression by continuous growth hormone administration. Molecular Endocrinology 1990; 4: 53–58
   PubMedGoogle Scholar